These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36535900)

  • 1. A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage.
    Nij Bijvank JA; Hof SN; Prouskas SE; Schoonheim MM; Uitdehaag BMJ; van Rijn LJ; Petzold A
    Brain; 2023 Jun; 146(6):2476-2488. PubMed ID: 36535900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network.
    Nij Bijvank JA; Strijbis EMM; Nauta IM; Kulik SD; Balk LJ; Stam CJ; Hillebrand A; Geurts JJG; Uitdehaag BMJ; van Rijn LJ; Petzold A; Schoonheim MM
    Neuroimage Clin; 2021; 32():102848. PubMed ID: 34624635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccadic delay in multiple sclerosis: A quantitative description.
    Nij Bijvank JA; Petzold A; Coric D; Tan HS; Uitdehaag BMJ; Balk LJ; van Rijn LJ
    Vision Res; 2020 Mar; 168():33-41. PubMed ID: 32065930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward an Automatic Assessment of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis Patients Using Eye Movement Analysis.
    García Cena CE; Gómez-Andrés D; Pulido-Valdeolivas I; Sánchez-Seco VG; Domingo-Santos A; Moreno-García S; Benito-León J
    Sensors (Basel); 2022 Oct; 22(21):. PubMed ID: 36365918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex.
    Tedone N; Preziosa P; Meani A; Pagani E; Vizzino C; Filippi M; Rocca MA
    Mol Psychiatry; 2023 Apr; 28(4):1783-1792. PubMed ID: 36806391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.
    Prinster A; Quarantelli M; Lanzillo R; Orefice G; Vacca G; Carotenuto B; Alfano B; Brunetti A; Morra VB; Salvatore M
    Mult Scler; 2010 Jan; 16(1):45-54. PubMed ID: 20028706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
    Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis.
    van Dongen MM; Bertelsmann FW; Polman CH
    J Neurol Sci; 1991 Mar; 102(1):25-31. PubMed ID: 1856729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
    Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
    Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.
    Geisseler O; Pflugshaupt T; Bezzola L; Reuter K; Weller D; Schuknecht B; Brugger P; Linnebank M
    Neuroimage Clin; 2016; 10():89-95. PubMed ID: 26759784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Carotenuto A; Valsasina P; Schoonheim MM; Geurts JJG; Barkhof F; Gallo A; Tedeschi G; Tommasin S; Pantano P; Filippi M; Rocca MA;
    Neurology; 2022 Nov; 99(22):e2517-e2530. PubMed ID: 36096690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
    Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH
    Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
    Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.